Explore

Streams

About Index

Index

By TNW

Cellectar

3200

Cellectar

PDC Cancer Therapeutics and Diagnostics, Targeted Delivery of Oncologic Payloads, #MultipleMyeloma #ClinicalTrial #HemOnc

Raised

$13.6M

Follow us

Also headquartered in Madison

Companies in the same industry

Alexa global traffic share

Terms of Service Privacy Policy Cookie Statement

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3

Acquired by

11 Apr 2011

Novelos Therapeutics

Latest funding Show all

$617,500

Debt financing - 2014

Undisclosed amount

Post-IPO equity - 2011

Location

Madison , United States

Headquarters

Explore Madison

Doyenne, Epic, Cellectar, & More: This Week’s Wisconsin Watchlist

Cellectar Biosciences Shutting Down Manufacturing Operations

Manufacturing Health

Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist

Gener8tor, Shine, Cellectar, & More: This Week’s Wisconsin Watchlist

Epic, Zuckerberg, Cellectar, & More: This Week’s Wisconsin Watchlist

WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug

Legal Health Science

After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future

Cellectar Awarded Another Cancer Drug Patent

Cellectar Announces $8M Stock Offering, Sending Shares Lower

Earnings Stock markets